Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONTARGET and TRANSCEND: Telmisartan and Ramipril in High-Risk Cardiovascular Patients
NCT00153101Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2001
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 41
01
Overview
Phase 4, randomised, double-blind trial of telmisartan in cardiovascular disease (CVD), sponsored by Boehringer Ingelheim. Started Nov 2001; status: completed.
02
Drugs
telmisartan
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00153101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00153101.